Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ABSSSI”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT04919954
What this trial is testing

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Who this might be right for
DiabetesWound InfectionABSSSI+1 more
Hartford Hospital 12
Not applicableEnded earlyNCT02991131
What this trial is testing

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study

Who this might be right for
Skin Disease, Infectious
Bayer 108
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Large-scale testing (Phase 3)Study completedNCT01252719
What this trial is testing

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Who this might be right for
Wound InfectionAbscessSystemic Inflammation+1 more
Melinta Therapeutics, Inc. 968
Not applicableStudy completedNCT04959799
What this trial is testing

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Who this might be right for
DiabetesInfection
Aziende Chimiche Riunite Angelini Francesco S.p.A 98
Testing effectiveness (Phase 2)Study completedNCT02426918
What this trial is testing

Study of Debio 1450 for Bacterial Skin Infections

Who this might be right for
Bacterial Infections
Debiopharm International SA 330
Early research (Phase 1)Study completedNCT06394518
What this trial is testing

Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Prosthetic Joints Infection (PJI)
TenNor Therapeutics Inc. 32
Not applicableUnknownNCT01724671
What this trial is testing

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

Who this might be right for
MRSA InfectionBacteremiaABSSSI+1 more
CPL Associates 30
Post-approval studies (Phase 4)Study completedNCT02582203
What this trial is testing

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

Who this might be right for
Skin Diseases, InfectiousStaphylococcal Skin Infections
Wayne State University 174
Post-approval studies (Phase 4)Study completedNCT02452918
What this trial is testing

Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
The Medicines Company 17
Testing effectiveness (Phase 2)Study completedNCT02269319
What this trial is testing

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Bacterial Infections
MicuRx 120
Not applicableStudy completedNCT04298463
What this trial is testing

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Aziende Chimiche Riunite Angelini Francesco S.p.A 184
Post-approval studies (Phase 4)Study completedNCT02961764
What this trial is testing

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Allergan 313
Testing effectiveness (Phase 2)Study completedNCT00949130
What this trial is testing

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Novexel Inc 180
Testing effectiveness (Phase 2)Study completedNCT01519492
What this trial is testing

Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsWound InfectionCutaneous Abscess+2 more
Affinium Pharmaceuticals, Ltd 103
Large-scale testing (Phase 3)Study completedNCT03176134
What this trial is testing

Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Merck Sharp & Dohme LLC 100
Not applicableStudy completedNCT01700842
What this trial is testing

Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia

Who this might be right for
Bacterial Skin Diseases
AstraZeneca 3,000
Large-scale testing (Phase 3)Study completedNCT02607618
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 613
Large-scale testing (Phase 3)Study completedNCT02600611
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 600
Post-approval studies (Phase 4)Ended earlyNCT03372941
What this trial is testing

Hospital Avoidance Strategies for ABSSSI

Who this might be right for
Skin Infection
Washington University School of Medicine 11
Next Page